Posts

Showing posts from May, 2022

DelveInsight’s Trending Reports 2022: Chondrosarcoma Market, Microsatellite Stable Colorectal Cancer Market, Rituximab Biosimilars Insight, Pain Management Devices Market, 22q11.2 Deletion Syndrome Market.

Chondrosarcoma Market Chondrosarcoma is a bone sarcoma that develops in the cartilage cells. It mostly affects adults above the age of 40 and the most common sites are the upper arm, pelvis and thigh bone. Chondrosarcomas can be subdivided in several ways: by histologic grade, whether they arise de novo (primary) or from benign lesions (secondary), by location within the bone (central or peripheral), or by syndrome. Some of the facts: ·          According to the US Surveillance, Epidemiology and End Results Program, Chondrosarcomas contribute 30% among different types of bone cancer. ·          Chondrosarcomas develops most often in adults, with an average age at diagnosis of 51. Less than 5% of cases occur in patients younger than 20. ·          Chondrosarcoma is a tumor of adulthood and older age. The majority of patients are older than 50 years of age at ...